Sally Hampton

Vice President, Research
KalVista Pharmaceuticals, Ltd
Porton Down, England, United Kingdom

Presentation(s):

• PB0536 - Oral Factor XIIa inhibitor KV998086 protects against FeCl3 induced thrombosis in mice.

  Monday, June 26, 2023
  18:30 – 19:30 ET